|
| 迪哲医药-U(688192)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-07-01 | 22301.33 | 53.65% | 40773.31 | 792.00 | 12308.50 | 29.61% | 追加承诺限售股份上市流通 | | 2025-01-02 | 5745.18 | 13.94% | 18116.98 | 23093.33 | 11953.50 | 29.01% | 首发原股东限售股份 | | 2024-12-27 | 418.30 | 1.02% | 12371.80 | 28838.51 | 11953.50 | 29.01% | 股权激励期权行权 | | 2023-12-11 | 120.00 | 0.29% | 11953.50 | 28861.64 | 3880.01 | 9.51% | 首发战略配售股份 | | 2023-07-17 | 7953.49 | 19.49% | 11833.50 | 28981.64 | 3880.01 | 9.51% | 首发原股东限售股份 | | 2022-06-10 | 185.05 | 0.46% | 3880.01 | 36538.30 | 3880.01 | 9.60% | 首发机构配售股份 | | 2021-12-10 | 3694.96 | 9.24% | 3694.96 | 36305.05 | 3694.96 | 9.24% | 首发一般股份 |
|